Prothena
PRTA
$20.56
Share price
0.00%
Change (1 day)
-62.47%
Change (1 year)
Categories
EPS for Prothena (PRTA)
EPS in 2023 (TTM): -$2.76
According to Prothena's latest financial reports the company's current EPS (TTM) is -$2.76. In 2022 the company made an earnings per share (EPS) of -$2.50 a decrease over its 2021 EPS that were of $1.39.
EPS history for Prothena from 2012 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.76 | 10.4% |
| 2022 | -$2.50 | -279.86% |
| 2021 | $1.39 | -149.82% |
| 2020 | -$2.79 | 43.08% |
| 2019 | -$1.95 | -50.51% |
| 2018 | -$3.94 | -2.96% |
| 2017 | -$4.06 | -12.88% |
| 2016 | -$4.66 | 77.19% |
| 2015 | -$2.63 | 3187.5% |
| 2014 | -$0.08000 | -96.4% |
| 2013 | -$2.22 | -10.16% |
| 2012 | -$2.47 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amarin Corporation
AMRN | -$0.13 | -95.37% | 🇮🇪 Ireland |
 Alnylam Pharmaceuticals
ALNY | -$4.11 | 48.91% | 🇺🇸 USA |
 Alkermes ALKS | $1.30 | -147.10% | 🇮🇪 Ireland |